GLP-1 weight‑loss meds spark rising emergency calls in Washington
Washington’s poison center saw GLP-1 drug–related calls double from 211 in 2024 to 421 in 2025, as at‑home dosing and unfamiliarity with syringes contribute to severe nausea, vomiting, and emergencies. The rise is linked to brand‑name meds like Ozempic and Wegovy and off‑brand/compounded versions sold online, with regulators evaluating risks. Experts urge using licensed healthcare providers, following dosing instructions, avoiding compounded products when possible, and keeping the 24/7 poison‑control number 1-800-222-1222 handy.